Physician profile
Benito Lopez
NPI 1033640685
$70,401.72
in general payments reported to CMS, 2019-2025
62 companies · $42K in 2025
The $42K reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,837 · 2022: $3,803 · 2023: $13K · 2024: $6,506 · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $13K · Travel and Lodging: $6,453 · Honoraria: $4,198 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21,602.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,745.46 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,650.00 |
| Travel and Lodging | $6,452.82 |
| Honoraria | $4,198.00 |
| Education | $113.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17,650.40 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Corcept Therapeutics | $10,938.04 | 2022-2025 | Korlym |
| Insulet Corporation | $9,659.75 | 2022-2025 | Omnipod, Omnipod |
| Intuity Medical INC | $7,375.45 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Novo Nordisk INC | $2,480.54 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Medtronic, INC. | $2,202.15 | 2021-2025 | Minimed 780g, Inceptiv, Synchromedii |
| Dexcom, INC. | $1,845.26 | 2021-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Astrazeneca Pharmaceuticals LP | $1,749.15 | 2021-2025 | Lokelma, Farxiga |
| Mannkind Corporation | $1,415.91 | 2022-2025 | Afrezza |
| Ascensia Diabetes Care US INC. | $1,322.45 | 2024-2025 | |
| Lilly USA, LLC | $1,295.50 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $787.75 | 2024-2025 | Evenity, Tepezza, Repatha |
| Xeris Pharmaceuticals, INC. | $777.63 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Amarin Pharma, INC. | $727.73 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $718.69 | 2021-2025 | Jardiance |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $662.82 | 2021-2025 | Nexletol, Nexlizet |
| Novartis Pharmaceuticals Corporation | $633.12 | 2021-2025 | |
| Averitas Pharma INC. | $619.63 | 2024-2025 | Qutenza |
| Radius Health, INC. | $550.90 | 2022-2025 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $533.77 | 2021-2025 | |
| Abbvie INC. | $515.94 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $495.60 | 2021-2025 | Xifaxan |
| Astellas Pharma US INC | $429.87 | 2021-2025 | Veozah |
| Optinose US, INC. | $349.49 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $335.41 | 2021-2025 | |
| Kyowa Kirin, INC. | $308.01 | 2022-2025 | Crysvita |
| Tandem Diabetes Care, INC. | $297.25 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Recordati_rare_diseases_inc. | $296.22 | 2023-2025 | Isturisa, Signifor Lar |
| Horizon Therapeutics Plc | $293.98 | 2021-2023 | Tepezza |
| Ultragenyx Pharmaceutical INC. | $213.58 | 2022-2023 | |
| Cequr Corporation | $201.79 | 2022-2025 | Cequr Simplicity |
| Alexion Pharmaceuticals, INC. | $200.61 | 2021-2025 | Strensiq |
| Inspire Medical Systems, INC. | $190.94 | 2023-2025 | Inspire |
| Amryt Pharma Holdings LTD | $186.53 | 2023 | Mycapssa |
| Beta Bionics, INC. | $179.36 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Merck Sharp & Dohme LLC | $164.71 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $162.74 | 2024-2025 | Crenessity |
| Janssen Pharmaceuticals, INC | $156.07 | 2021-2022 | |
| Biomarin Pharmaceutical INC. | $133.93 | 2025 | Voxzogo 1.2mg |
| Madrigal Pharmaceuticals | $110.08 | 2024-2025 | Rezdiffra, Resmetirom |
| Glaxosmithkline, LLC. | $105.54 | 2022 | |
| Ucb, INC. | $103.72 | 2022 | |
| Redhill Biopharma INC. | $103.06 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $102.60 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.22 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $78.34 | 2021-2022 | |
| Genentech USA, INC. | $78.33 | 2021-2022 | |
| Pfizer INC. | $73.70 | 2021 | |
| Nevro Corp. | $70.61 | 2024 | Senza |
| Biohaven Pharmaceuticals, INC. | $62.42 | 2021 | |
| Urovant Sciences INC | $57.18 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $46.20 | 2025 | Voquezna |
| Abiomed | $45.00 | 2025 | |
| Paratek Pharmaceuticals, INC. | $34.15 | 2022 | |
| Biogen, INC. | $33.92 | 2021 | |
| Antares Pharma, INC. | $32.56 | 2023 | Tlando, Nocdurna, Xyosted |
| Sandoz INC. | $31.95 | 2025 | |
| Arbor Pharmaceuticals, INC. | $25.84 | 2021 | |
| Soleno Therapeutics, INC. | $22.20 | 2025 | Vykat Xr |
| Ironwood Pharmaceuticals, INC | $15.79 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $14.58 | 2024 | Imcivree |
| Tolmar, INC. | $14.06 | 2025 | Jatenzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benito Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.